💨 Abstract
Spyre Therapeutics (SYRE) reported a first-quarter loss of $44.8 million, or 74 cents per share, exceeding Wall Street's expectation of a 76-cent loss per share, according to Zacks Investment Research.
Courtesy: wtop.com
Summarized by Einstein Beta 🤖
Suggested
BetMGM Bonus Code WTOP150: Get $150 NBA Promo for Warriors-Wolves -
Banco Itau: Q1 Earnings Snapshot -
Alabama sets a June date for its 5th execution using nitrogen gas -
Bet365 Bonus Code WTOP365: Claim $150 Bonus for Warriors-Wolves, Any Game -
Pope Leo XIV brings hope to Chicago sports fans, and the Knicks for their Villanova ties -
Asbestos clinic forced to close in Montana town where thousands have been sickened by dust -
AP PHOTOS: Europa League and Conference League semifinals -
Rafael Devers tells Red Sox he won’t move to first base -
NXT: Q1 Earnings Snapshot -
Western Copper: Q1 Earnings Snapshot -
Powered by MessengerX.io